Additional investigations will be required to elucidate the mechanisms by which Sirt2 delays c-MYC-driven HCC tumorigenesis in vivo, possibly through a regulatory pathway involving ubiquitination as previously reported [16]. The gene discussed is SIRT2; the disease is hepatocellular carcinoma.